Similarly, EGFR, a TSA, plays a crucial role in the development and progression of solid tumors and has emerged as a significant therapeutic target in various cancers such as NSCLC, breast, gastroesophageal, colorectal cancers, and GBM. Here, EGFR is linked to colorectal cancer.